Pharmacologic inhibition of preterm labor.
Preterm labor is responsible for a majority of cases of perinatal morbidity and deaths. Prevention of preterm labor is not usually possible; thus pharmacologic treatment is the only recourse available. Numerous agents have been used to treat preterm labor, but none has proved to be superior. This report reviews the current information available about the pharmacology of labor-inhibiting drugs and discusses the clinical approach to the management of preterm labor.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology; D003981:Diazoxide / Q000009:adverse effects / Q000494:pharmacology; D000431:Ethanol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007556:Isoxsuprine / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000009:adverse effects / Q000494:pharmacology; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011374:Progesterone / Q000627:therapeutic use; D011448:Prostaglandin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D012312:Ritodrine / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D011448:Prostaglandin Antagonists; D000431:Ethanol; D011374:Progesterone; D008278:Magnesium Sulfate; D012312:Ritodrine; D013726:Terbutaline; D003981:Diazoxide; D007556:Isoxsuprine